Hide metadata

dc.date.accessioned2023-11-28T17:40:46Z
dc.date.available2023-11-28T17:40:46Z
dc.date.created2023-10-06T12:30:37Z
dc.date.issued2023
dc.identifier.citationSolberg, Ole Geir Aaberge, Lars Bosse, Gerhard Ueland, Thor Gullestad, Lars Aukrust, Pål Stavem, Knut . Microvascular function and inflammatory activation in Takotsubo cardiomyopathy. ESC Heart Failure. 2023
dc.identifier.urihttp://hdl.handle.net/10852/106016
dc.description.abstractAbstract Aims The aim of this study was to determine microvascular function in the acute phase of Takotsubo syndrome (TTS) and to identify inflammatory mediators that could reflect TTS‐induced pathology. Methods and results The study included 20 females [median age 65 years; interquarile range (IQR) = 58–70 years] with TTS according to the Mayo diagnostic criteria. During heart catheterization, we determined the index of microvascular resistance (IMR) and drew blood samples almost simultaneously from the aorta and coronary sinus. Cardiac magnetic resonance imaging (MRI) was done in the acute phase. We present descriptive coronary physiology and cardiac MRI data and compare inflammatory biomarkers between samples from the aorta, coronary sinus, and venous samples after 3 months using the Wilcoxon signed‐rank test. For comparison, we also analysed the actual biomarkers in venous blood from 15 healthy female controls. A supplementary analysis explored Spearman's rank correlation between the inflammatory biomarkers, IMR, MRI data, and cardiac biomarkers. The median IMR was 16.5 mmHg·s (IQR = 10.5–28.2 mmHg·s), which was only slightly higher than that in the reference populations. Seven (35%) of the study subjects had IMR > 25 mmHg·s, suggesting a microvascular dysfunction. IMR was not affected by time from symptom onset. According to MRI, the apical region of the left ventricle was affected in 65% of the subjects. The median ejection fraction was 41% (IQR = 31–48%). Biomarker analyses revealed elevation of markers for extracellular matrix remodelling and fibrosis, inflammation, immune activation, and upstream inflammation as compared with healthy controls. Only the levels of interleukin (IL)‐1 receptor antagonist and soluble T‐cell immunoglobulin mucin domain‐3 (sTIM‐3) were higher in the coronary sinus than in the aorta. No variable was significantly correlated with IMR. The IL‐6 level in the aorta was inversely correlated with the left ventricular ejection fraction. Growth differentiation factor‐15, osteoprotegerin, and von Willebrand factor levels in both aorta and coronary sinus were positively correlated with N‐terminal‐pro‐brain‐natriuretic peptide, while the correlations of IL‐6 and sTIM‐3 with N‐terminal‐pro‐brain‐natriuretic peptide were restricted to the aorta and coronary sinus, respectively. While most of the markers were within normal limits after 3 months, matrix metalloproteinase‐9 increased during follow‐up to reach levels higher than those in the healthy controls. Conclusion The median IMR was only slightly elevated in this study, but about one‐third of the patients had values indicating microvascular dysfunction. The present study supports the involvement of several inflammatory pathways in TTS, including monocyte/macrophage activation, with sTIM‐3 as a potential novel marker.
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleMicrovascular function and inflammatory activation in Takotsubo cardiomyopathy
dc.title.alternativeENEngelskEnglishMicrovascular function and inflammatory activation in Takotsubo cardiomyopathy
dc.typeJournal article
dc.creator.authorSolberg, Ole Geir
dc.creator.authorAaberge, Lars
dc.creator.authorBosse, Gerhard
dc.creator.authorUeland, Thor
dc.creator.authorGullestad, Lars
dc.creator.authorAukrust, Pål
dc.creator.authorStavem, Knut
cristin.unitcode185,53,48,14
cristin.unitnameInstitutt for indremedisinsk forskning
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2182429
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=ESC Heart Failure&rft.volume=&rft.spage=&rft.date=2023
dc.identifier.jtitleESC Heart Failure
dc.identifier.volume10
dc.identifier.issue5
dc.identifier.startpage3216
dc.identifier.endpage3222
dc.identifier.pagecount0
dc.identifier.doihttps://doi.org/10.1002/ehf2.14461
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2055-5822
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International